Toine Cornelus Gerardus Egberts

Toine Cornelus Gerardus Egberts

Auto-generated profile, based on publicly available information

Toine Cornelus Gerardus Egberts

Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht, The Netherlands

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 September 2005 in Journal of the American Geriatrics Society
Verified
Journal Article
Closed access
PDF file
KKKees J. Kalisvaart
Kees J. Kalisvaart
JJJos F. M. De Jonghe
Jos F. M. De Jonghe
MBMarja J. Bogaards
Marja J. Bogaards
RVRalph Vreeswijk
Ralph Vreeswijk
TEToine C. G. Egberts
Toine C. G. Egberts
WGWillem A. Van Gool
Willem A. Van Gool

1 May 2015 in The Lancet Haematology
Verified
Journal Article
Closed access
RARick Admiraal
Rick Admiraal
CKCharlotte van Kesteren
Charlotte van Kesteren
CZCornelia M Jol-Van der Zijde
Cornelia M Jol-Van der Zijde
ALArjan C Lankester
Arjan C Lankester
MBMarc B Bierings
Marc B Bierings
JBJaap J Boelens
Jaap J Boelens

1 January 2000 in Drug Safety
Verified
Journal Article
Closed access
PDF file
PBPatricia M.L.A. van Den Bemt
Patricia M.L.A. van Den Bemt
TEToine C.G. Egberts
Toine C.G. Egberts
LBLolkje T.W. de Jong-Van Den Berg
Lolkje T.W. de Jong-Van Den Berg
JBJacobus R.B.J. Brouwers
Jacobus R.B.J. Brouwers

24 January 2005 in Epilepsia
Verified
Journal Article
Open access
PDF file
PSPatrick C. Souverein
Patrick C. Souverein
DWDavid J. Webb
David J. Webb
HPHans Petri
Hans Petri
JWJohn Weil
John Weil
VSVictoria van Staa
Victoria van Staa
TEToine Egberts
Toine Egberts
Summary:  Purpose: To compare the incidence of various fractures in a cohort of patients with epilepsy with a reference cohort of patients not having epilepsy. Methods: Patients were included in the epilepsy cohort if they had at least one diagnosis of epilepsy in their medical history and had sufficient evidence of “active” epilepsy (use of antiepileptic drugs, diagnoses) after the practice was included in the General Practice Research Database (GPRD). Two reference patients were sampled for each patient with epilepsy from the same practice. Primary outcome was the occurrence of any fracture during follow‐up. Poisson regression analysis was used to estimate incidence density ratios (IDRs). Results: The study population comprised 40,485 and 80,970 patients in the epilepsy and reference cohorts, respectively. The median duration of follow‐up was ∼3 years. The overall incidence rate in the epilepsy cohort was 241.9 per 10,000 person‐years. This rate was about twice as high as that in reference cohort: age‐ and sex‐adjusted IDR, 1.89 (95% CI, 1.81–1.98). When comparing IDRs among the different groups of fractures, the highest relative‐risk estimate was found for hip and femur fractures (adjusted IDR, 2.79; 95% CI, 2.41–3.24). IDRs were consistently elevated across age and sex groups and across fracture subtypes. Conclusions: The overall risk of fractures was nearly twice as high among patients with epilepsy compared with the general population. The relative fracture risk was highest for hip and femur. Further study is necessary to elucidate whether this elevated risk is due to the disease, the use of antiepileptic drugs, or both.

8 August 2006 in European Journal of Clinical Pharmacology
Verified
Journal Article
Closed access
PDF file
TVTessa Ververs
Tessa Ververs
HKHans Kaasenbrood
Hans Kaasenbrood
GVGerard Visser
Gerard Visser
FSFred Schobben
Fred Schobben
LBLolkje de Jong-Van Den Berg
Lolkje de Jong-Van Den Berg
TEToine Egberts
Toine Egberts

29 June 2011 in Arthritis & Rheumatism
Verified
Journal Article
Closed access
PDF file
MBMaja Bulatović
Maja Bulatović
MHMarloes W. Heijstek
Marloes W. Heijstek
MVMarleen Verkaaik
Marleen Verkaaik
EDE. H. Pieter van Dijkhuizen
E. H. Pieter van Dijkhuizen
WAWineke Armbrust
Wineke Armbrust
NWNico M. Wulffraat
Nico M. Wulffraat